Sleep

The DSM-V sleep-wake disorders nosology: an update and an invitation to the sleep community.

Sleep

Reynolds CF, Redline S

The DSM-V sleep-wake disorders nosology: an update and an invitation to the sleep community.

Sleep

Reynolds CF, Redline S

Psychomotor performance deficits and their relation to prior nights' sleep among individuals with primary insomnia.

Sleep

Edinger JD, Means MK, Carney CE, Krystal AD

Psychomotor performance deficits and their relation to prior nights' sleep among individuals with primary insomnia.

Sleep

Edinger JD, Means MK, Carney CE, Krystal AD

Long-term efficacy and safety of zolpidem extended-release 12.5 mg, administered 3 to 7 nights per week for 24 weeks, in patients with chronic primary insomnia: a 6-month, randomized, double-blind, placebo-controlled, parallel-group, multicenter study.

Sleep

Krystal AD, Erman M, Zammit GK, Soubrane C, Roth T

Long-term efficacy and safety of zolpidem extended-release 12.5 mg, administered 3 to 7 nights per week for 24 weeks, in patients with chronic primary insomnia: a 6-month, randomized, double-blind, placebo-controlled, parallel-group, multicenter study.

Sleep

Krystal AD, Erman M, Zammit GK, Soubrane C, Roth T

Nightly treatment of primary insomnia with eszopiclone for six months: effect on sleep, quality of life, and work limitations.

Sleep

Walsh JK, Krystal AD, Amato DA, Rubens R, Caron J, Wessel TC, Schaefer K, Roach J, Wallenstein G, Roth T

Nightly treatment of primary insomnia with eszopiclone for six months: effect on sleep, quality of life, and work limitations.

Sleep

Walsh JK, Krystal AD, Amato DA, Rubens R, Caron J, Wessel TC, Schaefer K, Roach J, Wallenstein G, Roth T

The possibility of preventing functional impairment due to sleep loss by pharmacologically enhancing sleep.

Sleep

Krystal AD

The possibility of preventing functional impairment due to sleep loss by pharmacologically enhancing sleep.

Sleep

Krystal AD

Pages